A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer.

Luo, Jian; Peng, Jiayu; Xiao, Wanying; Huang, Shujing; Cao, Yanqing; Wang, Ting; Wang, Xicheng

Luo, Jian; Peng, Jiayu; Xiao, Wanying; Huang, Shujing; Cao, Yanqing; Wang, Ting; Wang, Xicheng.

Afiliação

Luo J; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Peng J; Department of Radiation, Sun Yat-sen University Cancer Center, Guangzhou, China.
Xiao W; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Huang S; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Cao Y; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Wang T; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Wang X; Department of Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.

Front Genet ; 13: 984696, 2022.

Article em En | MEDLINE | ID: mdl-36092933

Palavras-chave

colon cancer; immune; lncRNA; necroptosis; nomogram

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google